IMMUTEP Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Aug 21, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Aug 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, company-information, foreign-private-issuer
TL;DR
IMMUTEP Ltd (formerly Prima BioMed) filed a 6-K on Aug 20, 2024, confirming its foreign private issuer status and Sydney HQ.
AI Summary
On August 20, 2024, IMMUTEP Ltd filed a Form 6-K. The filing indicates that the company, previously known as Prima BioMed Ltd until November 19, 2010, is a foreign private issuer based in Sydney, Australia. IMMUTEP Ltd operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides an update on IMMUTEP Ltd's status as a foreign private issuer and its corporate information, which is relevant for investors tracking the company's regulatory compliance and basic details.
Risk Assessment
Risk Level: low — This filing is a routine administrative update and does not contain material financial or operational news that would inherently increase risk.
Key Players & Entities
- IMMUTEP Ltd (company) — Filer
- Prima BioMed Ltd (company) — Former company name
- August 20, 2024 (date) — Filing date
- November 19, 2010 (date) — Date of name change
- Sydney, Australia (location) — Company headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically used to provide information that the company makes or is required to make public in its home country.
When was IMMUTEP Ltd previously known by another name?
IMMUTEP Ltd was formerly known as Prima BioMed Ltd, with the date of the name change being November 19, 2010.
Where is IMMUTEP Ltd's principal executive office located?
IMMUTEP Ltd's principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
What is IMMUTEP Ltd's Standard Industrial Classification (SIC) code?
IMMUTEP Ltd's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Does IMMUTEP Ltd file its annual reports under Form 20-F or Form 40-F?
IMMUTEP Ltd indicates that it files its annual reports under cover of Form 20-F.
Filing Stats: 263 words · 1 min read · ~1 pages · Grade level 17.2 · Accepted 2024-08-20 20:56:56
Filing Documents
- d863387d6k.htm (6-K) — 9KB
- d863387dex991.htm (EX-99.1) — 10KB
- g863387image1.jpg (GRAPHIC) — 13KB
- 0001193125-24-203874.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: August 20, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer